1. Home
  2. SOTK vs PLX Comparison

SOTK vs PLX Comparison

Compare SOTK & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

N/A

Current Price

$4.52

Market Cap

72.1M

Sector

Technology

ML Signal

N/A

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

N/A

Current Price

$2.70

Market Cap

182.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOTK
PLX
Founded
1975
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
182.9M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
SOTK
PLX
Price
$4.52
$2.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
40.9K
685.3K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
37.50
N/A
EPS
0.05
0.27
Revenue
$20,909,315.00
$52,744,000.00
Revenue This Year
$4.02
$36.81
Revenue Next Year
$10.95
N/A
P/E Ratio
$89.60
$10.00
Revenue Growth
1.97
N/A
52 Week Low
$3.40
$1.60
52 Week High
$6.24
$3.19

Technical Indicators

Market Signals
Indicator
SOTK
PLX
Relative Strength Index (RSI) 36.62 57.38
Support Level $3.81 $2.59
Resistance Level $5.72 $2.71
Average True Range (ATR) 0.27 0.10
MACD -0.06 0.00
Stochastic Oscillator 21.62 58.06

Price Performance

Historical Comparison
SOTK
PLX

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: